Report Feature
Sickle Cell Disease Treatment Trends and Forecast
The future of the global sickle cell disease treatment market looks promising with opportunities in the hospital and specialty clinic markets. The global sickle cell disease treatment market is expected to grow with a CAGR of 28.2% from 2024 to 2030. The major drivers for this market are raising awareness of illnesses, improvements in medical technology and research, as well as an increasing need for efficient treatments, along with rising disposable incomes.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Sickle Cell Disease Treatment by Segment
The study includes a forecast for the global sickle cell disease treatment by treatment, end use, and region.Sickle Cell Disease Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
• Blood Transfusion
• Pharmacotherapy
• Bone Marrow Transplant
Sickle Cell Disease Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Specialty Clinics
• Others
Sickle Cell Disease Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Sickle Cell Disease Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies sickle cell disease treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the sickle cell disease treatment companies profiled in this report include-• Novartis
• Pfizer
• Bluebird Bio
• CSL
• Emmaus Life Sciences
• Bristol Myers Squibb Company
• CRISPR Therapeutics
• Agios Pharmaceuticals
• Novo Nordisk
• Medunik
Sickle Cell Disease Treatment Market Insights
Lucintel forecasts that pharmacotherapy is expected to witness the highest growth over the forecast period. Within this market, hospital is expected to witness the higher growth due to rising incidence of sickle cell disease, improvements in medical technology, and an increased understanding of the need for specialist care for those with this hereditary condition. North America is expected to witness highest growth over the forecast period due to growing understanding of SCD and how to treat it, scientific developments, and the requirement for efficient treatments.Features of the Global Sickle Cell Disease Treatment Market
Market Size Estimates: Sickle cell disease treatment market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Sickle cell disease treatment market size by treatment, end use, and region in terms of value ($B). Regional Analysis: Sickle cell disease treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different treatment, end use, and regions for the sickle cell disease treatment market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the sickle cell disease treatment market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.FAQ
Q1. What is the growth forecast for sickle cell disease treatment market? Answer: The global sickle cell disease treatment market is expected to grow with a CAGR of 28.2% from 2024 to 2030. Q2. What are the major drivers influencing the growth of the sickle cell disease treatment market? Answer: The major drivers for this market are raising awareness of illnesses, improvements in medical technology and research, as well as an increasing need for efficient treatments, along with rising disposable incomes. Q3. What are the major segments for sickle cell disease treatment market? Answer: The future of the global sickle cell disease treatment market looks promising with opportunities in the hospital and specialty clinic markets. Q4. Who are the key sickle cell disease treatment market companies? Answer: Some of the key sickle cell disease treatment companies are as follows:• Novartis
• Pfizer
• Bluebird Bio
• CSL
• Emmaus Life Sciences
• Bristol Myers Squibb Company
• CRISPR Therapeutics
• Agios Pharmaceuticals
• Novo Nordisk
• Medunik Q5. Which sickle cell disease treatment market segment will be the largest in future? Answer: Lucintel forecasts that pharmacotherapy is expected to witness the highest growth over the forecast period. Q6. In sickle cell disease treatment market, which region is expected to be the largest in next 5 years? Answer: North America is expected to witness highest growth over the forecast period due to growing understanding of SCD and how to treat it, scientific developments, and the requirement for efficient treatments. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.
Table of Contents
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the sickle cell disease treatment market by treatment (blood transfusion, pharmacotherapy, and bone marrow transplant), end use (hospitals, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Sickle Cell Disease Treatment Market, Sickle Cell Disease Treatment Market Size, Sickle Cell Disease Treatment Market Growth, Sickle Cell Disease Treatment Market Analysis, Sickle Cell Disease Treatment Market Report, Sickle Cell Disease Treatment Market Share, Sickle Cell Disease Treatment Market Trends, Sickle Cell Disease Treatment Market Forecast, Sickle Cell Disease Treatment Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
